Grant: Engage Grants Program
University of Victoria
$25,000.00
Engineering reproducible neural tissue from embryonic and induced pluripotent stem cells
FY 2011-12
Summary
Both embryonic stem (ES) and induced pluripotent stem (iPS) cells possess the property of pluripotency - the ability to become any cell type found in the body and this property makes them attractive targets for cell based therapies, including tissue engineering applications. One of the current challenges when engineering tissues using ES and iPS cells is being able to consistently replicate their behavior as these cells, including inducing them to differentiate into the mature cells found in the central nervous system. STEMCELL Technologies has developed a number of products to address these issues associated with stem cell biology and neural tissue engineering. The major goal of this project is to quantitatively evaluate how the use of STEMCELL Technologies products can be used to consistently engineer neural tissue from both mouse and human induced pluripotent stem (iPS) cell lines as compared to traditionally used differentiation methods.
This project will initiate a first time collaboration between Stem Cell Technologies and the Willerth laboratory at the University of Victoria. STEMCELL Technologies Inc is a privately-owned biotechnology company that develops specialty cell culture media, cell separation products and ancillary reagents for life science research. Dr. Willerth is an expert in the fields of stem cells and biomaterials. This project will compare the results of engineering neural tissue using STEMCELL Technologies products to traditionally used differentiation methods for both mouse and human iPS cell lines. Specifically, this project will analyze the effect of two specific STEMCELL Technologies products, StemAdhere substrate for the culture of stem cells and the STEMDiff Neural Induction kits, on neural differentiation of pluripotent stem cells.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
428826-2011
Name nom
Willerth, Stephanie
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Engineering reproducible neural tissue from embryonic and induced pluripotent stem cells
Keyword
NSERC
Application summary
Both embryonic stem (ES) and induced pluripotent stem (iPS) cells possess the property of pluripotency - the ability to become any cell type found in the body and this property makes them attractive targets for cell based therapies, including tissue engineering applications. One of the current challenges when engineering tissues using ES and iPS cells is being able to consistently replicate their behavior as these cells, including inducing them to differentiate into the mature cells found in the central nervous system. STEMCELL Technologies has developed a number of products to address these issues associated with stem cell biology and neural tissue engineering. The major goal of this project is to quantitatively evaluate how the use of STEMCELL Technologies products can be used to consistently engineer neural tissue from both mouse and human induced pluripotent stem (iPS) cell lines as compared to traditionally used differentiation methods.
This project will initiate a first time collaboration between Stem Cell Technologies and the Willerth laboratory at the University of Victoria. STEMCELL Technologies Inc is a privately-owned biotechnology company that develops specialty cell culture media, cell separation products and ancillary reagents for life science research. Dr. Willerth is an expert in the fields of stem cells and biomaterials. This project will compare the results of engineering neural tissue using STEMCELL Technologies products to traditionally used differentiation methods for both mouse and human iPS cell lines. Specifically, this project will analyze the effect of two specific STEMCELL Technologies products, StemAdhere substrate for the culture of stem cells and the STEMDiff Neural Induction kits, on neural differentiation of pluripotent stem cells.